Latest Asx News

Connected Minerals reports robust Phase 2 drilling results at its Etango North-East uranium project in Namibia, with 17 of 23 holes returning economic uranium grades and confirming promising geological parallels to a world-class deposit.

Helloworld Travel Limited has completed its acquisition of the remaining 50% stake in Mobile Travel Holdings, fully owning the mobile travel agency and significantly boosting its transaction volume.

South Harz Potash Limited is progressing its transition to a dual-asset strategy, raising A$2.58 million to support expansion while adopting a cautious approach to its core German potash project amid market weakness.

Findi Limited has arranged a new A$30 million debt facility and agreed to acquire Sphere, enhancing its digital payments ecosystem ahead of a planned FY27 Indian IPO. Despite short-term challenges, the company projects strong revenue growth and operational momentum in FY26.

Freehill Mining reports strong magnetite concentrate grades at its Yerbas Buenas project, while advancing its aggregates business and exploring copper-gold opportunities in Chile.

Central Petroleum has secured a new 1.3 petajoule gas supply agreement with McArthur River Mining, enhancing cash flow certainty through fixed pricing and take-or-pay terms.

Latrobe Magnesium Limited has received a non-binding Letter of Interest from the U.S. Export Import Bank to finance up to A$200 million for its Stage 2 Commercial Magnesium Plant, aiming to strengthen critical mineral supply chains for the U.S.

Dart Mining continues to reveal promising antimony mineralisation at its Coonambula project in Queensland, aligning with the new Australia-USA critical minerals pact. Assay results are pending, but visual drilling intercepts suggest significant potential.

CONNEQT Health reports robust sales momentum for its CONNEQT Pulse arterial health monitor, with quarterly sales growth exceeding 50% and a fresh order for 10,000 units to meet rising demand.

Power Minerals Limited is set to embark on an extensive drilling campaign at its Santa Anna Project in Brazil, aiming to expand high-grade rare earth and niobium mineralisation zones. The program kicks off with 2,000m of reverse circulation drilling in November 2025, paving the way for deeper exploration in 2026.

PYC Therapeutics has kicked off a global Phase 1b repeat dose study of its investigational drug PYC-001 targeting Autosomal Dominant Optic Atrophy, a rare genetic eye disease with no current treatments. Initial dosing has begun, with key data expected in the second half of 2026.

Pure Hydrogen Corporation has locked in a $2.5 million loan facility to accelerate its clean energy vehicle rollout, aiming to capitalise on a growing sales pipeline in Australia and the US.